| Literature DB >> 33893998 |
Dheeraj Bisht1, Deepak Kumar2, Dharmendra Kumar3,4, Kamal Dua2,5, Dinesh Kumar Chellappan6.
Abstract
Artemisia and its allied species have been employed for conventional medicine in the Northern temperate regions of North America, Europe, and Asia for the treatments of digestive problems, morning sickness, irregular menstrual cycle, typhoid, epilepsy, renal problems, bronchitis malaria, etc. The multidisciplinary use of artemisia species has various other health benefits that are related to its traditional and modern pharmaceutical perspectives. The main objective of this review is to evaluate the traditional, modern, biological as well as pharmacological use of the essential oil and herbal extracts of Artemisia nilagirica, Artemisia parviflora, and other allied species of Artemisia. It also discusses the botanical circulation and its phytochemical constituents viz disaccharides, polysaccharides, glycosides, saponins, terpenoids, flavonoids, and carotenoids. The plants have different biological importance like antiparasitic, antimalarial, antihyperlipidemic, antiasthmatic, antiepileptic, antitubercular, antihypertensive, antidiabetic, anxiolytic, antiemetic, antidepressant, anticancer, hepatoprotective, gastroprotective, insecticidal, antiviral activities, and also against COVID-19. Toxicological studies showed that the plants at a low dose and short duration are non or low-toxic. In contrast, a high dose at 3 g/kg and for a longer duration can cause toxicity like rapid respiration, neurotoxicity, reproductive toxicity, etc. However, further in-depth studies are needed to determine the medicinal uses, clinical efficacy and safety are crucial next steps.Entities:
Keywords: Artemisia; COVID-19; Essential oil; Pharmacological activity; Phytochemical constituents; Sesquiterpenes; Toxicological studies
Mesh:
Substances:
Year: 2021 PMID: 33893998 PMCID: PMC8067791 DOI: 10.1007/s12272-021-01328-4
Source DB: PubMed Journal: Arch Pharm Res ISSN: 0253-6269 Impact factor: 6.010
Chemical compositions of some medicinally active constituents of genus artemisia essential oils
| Compound | Relative content | Compound | Relative content |
|---|---|---|---|
| β-Myrcene | 0.2 | α-Phellrene | 2.1 |
| β-Pinene | 0.9 | Pinocarvone | 3.7 |
| α-Humulene | 0.3 | ( | 2.1 |
| α-Pinene | 1.1 | Sabinene | 14.3 |
| γ-Terpinene | 0.3 | Germacrene D | 2.1 |
| Caryophyllene | 1.3 | Camphor | 22.8 |
| Curcumene | 0.4 | Eucalyptol | 2.3 |
| Caryophyllene oxide | 0.6 | Camphene | 2.7 |
| DL-Limonene | 1.1 | α-Thujone | 14.6 |
| ( | 1.1 | 16.7 | |
| Total identified | 91.1 |
Fig. 1Some non-volatile constituents of Artemisia species
Fig. 2Some volatile constituents of Artemisia species
Fig. 3Some chemical constituents of genus artemisia i.e. flavonoids, phenolic acids, coumarin derivatives, monoterpene, and sesquiterpene
Phytochemical analysis of A. nilagirica extracts
| S. no. | Test | Chloroform | Diethyl ether | Ethanol | Hexane | Methanol | Petroleum ether |
|---|---|---|---|---|---|---|---|
| 1 | Phlobatannins | − | − | − | + | − | + |
| 2 | Glycosides | − | − | − | − | − | − |
| 3 | Flavonoids | ++ | + | ++ | ++ | ++ | + |
| 4 | Saponins | − | − | + | − | + | − |
| 5 | Amino acids | − | − | + | − | ++ | − |
| 6 | Carbohydrates | − | − | − | − | + | − |
| 7 | Alkaloids | ++ | ++ | ++ | ++ | ++ | + |
| 8 | Volatile oils | − | − | − | + | + | − |
| 9 | Phenol | ++ | + | ++ | + | ++ | + |
| 10 | Tannins | − | + | ++ | − | ++ | − |
| 11 | Terpenoids | ++ | ++ | ++ | ++ | ++ | ++ |
| 12 | Quinines | + | + | + | + | + | + |
| 13 | Hydrolysable tannins | − | − | − | − | − | − |
(−) = Absent, (+) = Present, (++) = Abundant
Extraction of oil from asunder segments of mugwort (A. vulgaris)
| Origin/parts | Procedure | Equipment | Yield (%) | References |
|---|---|---|---|---|
| China/leaves stems | Hydrodistillation | Clevenger | – | Wang et al. ( |
| Sebia/aerial parts | Hydrodistillation | Clevenger | – | Blagojevic et al. ( |
| North Lithuania/ aerial parts | Hydrodistillation with hexane diethyl ether combination | – | 0.2–0.4 | Judzentiene and Buzelyte ( |
| Turkey/aerial parts | Hyrodistillation | Clevenger | 0.40 | Erel et al. ( |
| Italy/aerial parts | Hydrodistillation | Likens-Nickerson apparatus | – | Mucciarelli et al. ( |
| Iran/aerial parts | Steam distillation | Clevenger | 1.4 | Alizedah et al. (2012) |
| Nepal/leaves | Steam distillation | Clevenger | – | Bhatt et al. ( |
| Cuba/aerial parts | Hydrodistillation | Clevenger | 0.1 | Pino et al. ( |
| India/aerial parts | Hydrodistillation | Clevenger | 0.16–0.5 | Haider et al. ( |
| Vietnam/aerial parts | Hydrodistillation | Clevenger | 0.32–1.14 | Thao et al. ( |
| India/stem | Hydrodistillation | Clevenger | – | Govindaraj and Kumari ( |
| Iran/aerial parts | Hydrodistillation | Clevenger | 0.25 | Bamoniri et al. ( |
Antimicrobial action of plant extracts from Artemisia nilagirica (Clarke) Pamp (Parameswari et al. 2019)
| Bacterial | The concentration of the leaf extract (µg) | Standard | |||
|---|---|---|---|---|---|
| 50 | 100 | 150 | 200 | ||
| 3 | 6 | 8 | 10 | 12 | |
| 11 | 13 | 15 | 18 | 20 | |
| 12 | 14 | 15 | 17 | 19 | |
| 12 | 14 | 16 | 18 | 40 | |
| – | – | – | – | 16 | |
| 13 | 16 | 17 | 19 | 43 | |
| – | – | – | – | 13 | |
| 12 | 14 | 16 | 18 | 33 | |